Ethinylestradio-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women With Polycystic Ovary Syndrome: Evaluation of the Metabolic Impact-Reference-Cited by-同舟云学术

Ethinylestradio-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women With Polycystic Ovary Syndrome: Evaluation of the Metabolic Impact

Published:2010-07 Issue:8 Volume:17 Page:767-775
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Guido Maurizio¹,Romualdi Daniela²,Campagna Giuseppe²,Ricciardi Luigi²,Bompiani Alessandro²,Lanzone Antonio³

Affiliation:

1. Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy,

2. Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy

3. Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy, OASI Institute for Research, Troina, Italy

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719110371515

Reference52 articles.

1. Polycystic Ovary Syndrome

2. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome

3. A systematic review of commonly used medical treatments for hirsutism in women

4. Treatment of PCOS in adolescence

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective study of fertility‐sparing treatment with chlormadinone acetate for endometrial carcinoma and atypical hyperplasia in young women;International Journal of Gynecology & Obstetrics;2021-10-04

2. COMBINED HORMONAL CONTRACEPTION AND NOT ONLY…;Medical Council;2017-12-30

3. Polycystic ovary syndrome: chemical pharmacotherapy;Expert Opinion on Pharmacotherapy;2015-05-22

4. The role of androgen and androgen receptor in skin-related disorders;Archives of Dermatological Research;2012-07-25

5. Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase-2 in Women with Polycystic Ovary Syndrome;Basic & Clinical Pharmacology & Toxicology;2012-05